Date

12 September 2024 - 1:00pm

Australia has implemented significant reforms to its vaping regulations to tighten control over the availability and distribution of vaping products to help curb the rise of vaping, particularly amongst young people.  

Rewatch our CHF Talks webinar as we broke down the pending changes to vaping regulations that will take effect from 1 October 2024 and how they will impact consumers, retailers, and the vaping community at large.

Our expert panel guided you through: 

  • Key Changes: What exactly is changing? 

  • Consumer Impact: How will these changes affect your vaping habits and purchasing options? 

  • Working with health professionals: What is the role of your GP and pharmacist and how can they support you? 

Whether you’re currently vaping, trying to quit or supporting someone to quit, or just curious about the new legislation, this webinar is a must-attend to stay informed and compliant. There will be a live Q&A session where you can ask your questions and get answers directly from the experts. 

Date: Thursday 12 September 2024 

Vaping links

Quitline: https://www.quit.org.au/landing/smoking-again  

TGA Vaping Hub: https://www.tga.gov.au/products/unapproved-therapeutic-goods/vaping-hub  

Hub quick link for consumers: https://www.tga.gov.au/products/unapproved-therapeutic-goods/vaping-hub/vapes-information-individuals-and-patients 

Some vaping facts: https://www.vapingfacts.org.au/ 

PSA’s guide on vaping reforms: https://www.psa.org.au/career-and-support/navigating-vaping-reforms/  

Guide to support quitting: https://www.health.nsw.gov.au/tobacco/Publications/e-cigarette-young-pdf  

GUEST PANELLISTS

Professor Nick Zwar

Professor Nick Zwar joined Bond University in 2019 as Executive Dean - Health Sciences and Medicine. He has a national and international reputation in health services research on prevention and management of chronic illness, with a focus on respiratory and cardiovascular diseases. Other clinical, teaching and research interests include tobacco control, immunisation and travel health. Professor Zwar has led the development, and contributed to several sets of Australian and international clinical practice guidelines and has over 200 peer-reviewed publications. Over the course of his academic career Nick has maintained involvement in clinical practice, working part time as a general practitioner for over 30 years.

Chris Campbell

Chris is the General Manager for Policy and Program Delivery at the Pharmaceutical Society of Australia. His work with the PSA focuses on improving medicine safety and quality through pharmacists and has been involved in many of the major advances in scope of practice of pharmacists including immunisation, administering medicines and prescribing. Chris oversees PSAs major projects, publications including APF and Australian Pharmacist, industry partnerships, standards and guidelines. Chris trained as a hospital pharmacist and has worked across community pharmacy and industry roles as a pharmacist for over 20 years. He is an Adjunct Senior Lecturer at University of Queensland School of Pharmacy and Research Fellow at the Queensland University of Technology.

Mandy Edlington

Mandy Edlington is the Acting Assistant Secretary of the Vaping Legislative Reform Branch at the Therapeutic Goods Administration (TGA) in the Australian Government Department of Health and Aged Care. She has worked in the Department since 2016, during which time Mandy has managed the provision of legal advice on matters of statutory interpretation, administrative law, legislative design and drafting, dispute resolution and enforcement action. Notably, she contributed significantly to the Department’s emergency response to COVID-19 and Australia’s first onshore manufacturing capacity for mRNA vaccines. More recently, Mandy led the design and development of legislative and regulatory measures to support the Government’s vaping reforms. Mandy has over 20 years’ experience as a legal adviser in the public sector, including at IP Australia, the Australian Pesticides and Veterinary Medicines Authority and the Department of Agriculture, Fisheries and Forestry.

Share